Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect

Cancer Research

Volumn 60, Issue 20, 2000, Pages 5710-5713

  Habuchi, Tomonori ^a   Liqing, Zhang ^a   Suzuki, Takehiro ^a   Sasaki, Ryusei ^a   Tsuchiya, Norihiko ^a   Tachiki, Hiroshi ^a   Shimoda, Naotake ^a   Satoh, Shigeru ^a   Sato, Kazunari ^a   Kakehi, Yoshiyuki ^b   Kamoto, Toshiyuki ^b   Ogawa, Osamu ^b   Kato, Tetsuro ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DOSAGE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RNA TRANSCRIPTION;

AGED; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, GENETIC; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE;

EID: 0034667481     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Estimates of the worldwide incidence of 25 major cancers in 1990
2. Descriptive epidemiology of prostate cancer in metropolitan Detroit
3. The geography of prostate cancer and its treatment in Japan
4. The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles
5. Cloning and sequence of the human gene for P450c17 (steroid 17 α-hydroxylase/17,20 lyase): Similarity with the gene for P450c21
6. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17
7. CYP17 and breast cancer risk: The polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1
8. A polymorphism in the CYP17 gene increases the risk of breast cancer
9. Association between CYP17 gene polymorphism and risk of breast cancer in young women
10. A polymorphism in the CYP17 gene is associated with male breast cancer
11. Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations
12. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer
13. Polymorphism T->-C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome
14. CYP17 genotype and breast cancer risk
15. Association between CYP17 polymorphisms and the development of breast cancer
16. Frequency of a polymorphism in the regulatory region of the 17 α-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states
17. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer
18. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
19. Prostate cancer associated with CYP17 genotype
20. A polymorphism in the CYP17 gene is associated with prostate cancer risk
21. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population
22. Comparison of various assay systems for prostate-specific antigen standardization
23. Histological grading and clinical staging of prostatic carcinoma
24. Urological tumours: Prostate
25. Endogenous hormones and breast cancer
26. Genetic control of human androgen metabolism by the CYP17 and SRD5A2 genes
27. Role of cytochrome P450c17 in polycystic ovary syndrome
28. Cytochrome P450c17α gene (CYPI7) polymorphism predicts use of hormone replacement therapy
29. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility
30. Possible association of CYP17 gene polymorphisms with the onset of rheumatoid arthritis
31. Genetic susceptibility of benign prostatic hyperplasia
32. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia
33. Cancer of the prostate among men with benign prostatic hyperplasia